{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:17:33Z","timestamp":1751948253720,"version":"3.41.2"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,7]]},"DOI":"10.7759\/cureus.87462","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T19:53:17Z","timestamp":1751917997000},"source":"Crossref","is-referenced-by-count":0,"title":["Antiphospholipid Syndrome in a Patient With IgA Nephropathy: A Rare and Challenging Clinical Overlap"],"prefix":"10.7759","author":[{"given":"Usamah","family":"Al-Anbagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem M","family":"Abusriwil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeez","family":"Palol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Emsalem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulqadir J","family":"Nashwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia D","year":"2018","unstructured":"Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018, 378:2010-21. 10.1056\/NEJMra1705454","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2015.0085","article-title":"The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus","volume":"3","author":"\u00dcnl\u00fc O","year":"2016","unstructured":"\u00dcnl\u00fc O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol. 2016, 3:75-84. 10.5152\/eurjrheum.2015.0085","journal-title":"Eur J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2004.01.002","article-title":"Pathogenesis of IgA nephropathy","volume":"24","author":"Barratt J","year":"2004","unstructured":"Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol. 2004, 24:197-217. 10.1016\/j.semnephrol.2004.01.002","journal-title":"Semin Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020081208","article-title":"O- and N-glycosylation of serum immunoglobulin A is associated with IgA nephropathy and glomerular function","volume":"32","author":"Dotz V","year":"2021","unstructured":"Dotz V, Visconti A, Lomax-Browne HJ, et al.. O- and N-glycosylation of serum immunoglobulin A is associated with IgA nephropathy and glomerular function. J Am Soc Nephrol. 2021, 32:2455-65. 10.1681\/ASN.2020081208","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.43","article-title":"The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults","volume":"77","author":"Coppo R","year":"2010","unstructured":"Coppo R, Troyanov S, Camilla R, et al.. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010, 77:921-7. 10.1038\/ki.2010.43","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.10.022","article-title":"An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"23","author":"Devreese KM","year":"2025","unstructured":"Devreese KM, Bertolaccini ML, Branch DW, et al.. An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies. J Thromb Haemost. 2025, 23:731-44. 10.1016\/j.jtha.2024.10.022","journal-title":"J Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria","volume":"75","author":"Barbhaiya M","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al.. The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol. 2023, 75:1687-702. 10.1002\/art.42624","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590031077.x","article-title":"Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy","volume":"59","author":"Hiki Y","year":"2001","unstructured":"Hiki Y, Odani H, Takahashi M, et al.. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001, 59:1077-85. 10.1046\/j.1523-1755.2001.0590031077.x","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.50","article-title":"IgA nephropathy","volume":"47","author":"Galla JH","year":"1995","unstructured":"Galla JH. IgA nephropathy. Kidney Int. 1995, 47:377-87. 10.1038\/ki.1995.50","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio JV","year":"2002","unstructured":"Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002, 347:738-48. 10.1056\/NEJMra020109","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher D","year":"2023","unstructured":"Pitcher D, Braddon F, Hendry B, et al.. Long-term outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2023, 18:727-38. 10.2215\/CJN.0000000000000135","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.63","article-title":"Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments","volume":"86","author":"Coppo R","year":"2014","unstructured":"Coppo R, Troyanov S, Bellur S, et al.. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014, 86:828-36. 10.1038\/ki.2014.63","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2013(07)29","article-title":"Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis","volume":"68","author":"Baradaran A","year":"2013","unstructured":"Baradaran A, Nasri H. Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis. Clinics (Sao Paulo). 2013, 68:10.6061\/clinics\/2013(07)29","journal-title":"Clinics (Sao Paulo)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00500.x","article-title":"\"Black swan in the kidney\": renal involvement in the antiphospholipid antibody syndrome","volume":"62","author":"Nzerue CM","year":"2002","unstructured":"Nzerue CM, Hewan-Lowe K, Pierangeli S, Harris EN. \"Black swan in the kidney\": renal involvement in the antiphospholipid antibody syndrome. Kidney Int. 2002, 62:733-44. 10.1046\/j.1523-1755.2002.00500.x","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01181","article-title":"Antiphospholipid syndrome nephropathy: from pathogenesis to treatment","volume":"9","author":"Tektonidou MG","year":"2018","unstructured":"Tektonidou MG. Antiphospholipid syndrome nephropathy: from pathogenesis to treatment. Front Immunol. 2018, 9:10.3389\/fimmu.2018.01181","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/387141-antiphospholipid-syndrome-in-a-patient-with-iga-nephropathy-a-rare-and-challenging-clinical-overlap","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T19:53:18Z","timestamp":1751917998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/387141-antiphospholipid-syndrome-in-a-patient-with-iga-nephropathy-a-rare-and-challenging-clinical-overlap"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.87462","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}